251 results
8-K
EX-10.1
ACHV
Achieve Life Sciences Inc.
29 Feb 24
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
4:41pm
, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(h)Material Changes; Undisclosed Events, Liabilities
8-K
ACHV
Achieve Life Sciences Inc.
29 Feb 24
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
4:41pm
to the completion of the Company’s financial closing procedures and any adjustments that may result from the completion of the audit of the Company’s financial
8-K
EX-10.1
9jcnwk hq21
25 May 23
Achieve Life Sciences Announces Pricing of $16.5 Million Registered Direct Offering
9:06am
8-K
EX-10.1
3xndonjs7s sob0p3n
17 May 23
Entry into a Material Definitive Agreement
8:07am
8-K
EX-10.1
9ggzl
27 Apr 22
Entry into a Material Definitive Agreement
8:06am
8-K
EX-10.1
6diooh
22 Dec 21
Entry into a Material Definitive Agreement
8:30am